diazepam has been researched along with cholecystokinin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (58.82) | 18.7374 |
| 1990's | 11 (32.35) | 18.2507 |
| 2000's | 3 (8.82) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baile, CA; McLaughlin, CL | 1 |
| de Oliveira, JP; Demol, P; Sarles, H; Singer, M | 1 |
| Adham, NF; Douglas, AP; Renner, IG; Rinderknecht, H | 1 |
| Bank, S; Barbezat, GO; Novis, BH; Odes, HS; Outim, L | 1 |
| Masoero, G; Saunders, JH; Wormsley, KG | 1 |
| Cohen, Y; Jacquot, C; Orosco, M; Rouch, C; Rybarczyk, MC | 1 |
| Harro, J; Lang, A; Vasar, E | 1 |
| Kubota, K; Matsuda, I; Sugaya, K; Sunagane, N; Uruno, T | 1 |
| Kubota, K; Matsuda, I; Matsuoka, Y; Sugaya, K; Terawaki, Y | 1 |
| Hodgson, OJ; Pullen, RG | 1 |
| Bouthillier, A; De Montigny, C | 1 |
| Furui, T; Go, VL; Kanawati, IS; Yaksh, TL | 1 |
| Kubota, K; Sugaya, K | 1 |
| Bareggi, SR; Bianchi, M; Mantegazza, P; Panerai, AE; Rovati, LC | 1 |
| Zetler, G | 5 |
| Levine, AS; Morley, JE | 1 |
| Crawley, JN; Goodwin, FK; Hays, SE; Paul, SM | 1 |
| Morley, JE | 1 |
| Brodin, E; Brodin, K; Rosén, A; Schött, E | 1 |
| Bonnafous, C; Bueno, L; Martinez, J | 1 |
| Fink, H; Gerhardt, P; Huston, JP; Voits, M | 1 |
| Hökfelt, T; Hughes, J; Jing-Xia, H; Seiger, Å; Wiesenfeld-Hallin, Z; Xiao-Jun, X | 1 |
| Berger, JE; Helton, DR; Rasmussen, K; Scearce, E | 2 |
| Andrews, N; File, SE; Rattray, M; Singhvi, S; Wu, PY | 1 |
| Becker, C; Benoliel, JJ; Hamon, M; Nevo, I | 1 |
| Ballaz, S; Barber, A; Del Río, J; Fortuño, A; García-López, MT; Gómez-Monterrey, I; González-Muñiz, R; Herranz, R; Martin-Martínez, M | 1 |
| Chen, Q; Meacham, C; Nakajima, A; Tang, YP | 1 |
| Amanzio, M; Asteggiano, G; Benedetti, F; Vighetti, S | 1 |
| Chung, L; Moore, SD | 1 |
1 review(s) available for diazepam and cholecystokinin
| Article | Year |
|---|---|
The neuroendocrine control of appetite: the role of the endogenous opiates, cholecystokinin, TRH, gamma-amino-butyric-acid and the diazepam receptor.
Topics: Appetite; Biogenic Amines; Cholecystokinin; Diazepam; Endorphins; gamma-Aminobutyric Acid; Hypothalamus; Peptides; Receptors, Drug; Thyrotropin-Releasing Hormone | 1980 |
1 trial(s) available for diazepam and cholecystokinin
| Article | Year |
|---|---|
Effect of diazepam and hyoscine butylbromide on response to secretin and cholecystokinin-pancreozymin in man.
Topics: Bicarbonates; Bilirubin; Butylscopolammonium Bromide; Cholecystokinin; Diazepam; Humans; Pancreatic Juice; Scopolamine Derivatives; Secretin; Time Factors; Trypsin | 1976 |
32 other study(ies) available for diazepam and cholecystokinin
| Article | Year |
|---|---|
Cholecystokinin, amphetamine and diazepam and feeding in lean and obese Zucker rats.
Topics: Animals; Body Weight; Cholecystokinin; Dextroamphetamine; Diazepam; Drug Interactions; Feeding Behavior; Female; Male; Obesity; Rats; Time Factors | 1979 |
[Effect of diazepam on the exocrine pancreatic secretion in the alcoholized and nonalcoholized dog].
Topics: Alcoholic Intoxication; Animals; Cholecystokinin; Diazepam; Dogs; Humans; Pancreas; Pancreatic Juice; Secretin; Stimulation, Chemical | 1977 |
Profiles of pure pancreatic secretions obtained by direct pancreatic duct cannulation in normal healthy human subjects.
Topics: Adult; Aged; Amylases; Catheterization; Cholecystokinin; Chymotrypsinogen; Diazepam; Female; Humans; Male; Meperidine; Middle Aged; Pancreatic Ducts; Pancreatic Elastase; Pancreatic Juice; Proteins; Scopolamine Derivatives; Secretin; Specimen Handling; Trypsin Inhibitors; Trypsinogen | 1978 |
The effect of diazepam on human pancreatic secretion.
Topics: Adult; Amylases; Bicarbonates; Cholecystokinin; Diazepam; Humans; Middle Aged; Pancreatic Juice; Premedication; Secretin; Secretory Rate | 1976 |
Interaction of cholecystokinin and diazepam: effects on brain monoamines.
Topics: 5-Hydroxytryptophan; Animals; Biogenic Monoamines; Brain Chemistry; Cerebral Cortex; Cholecystokinin; Corpus Striatum; Diazepam; Hippocampus; Homovanillic Acid; In Vitro Techniques; Male; Norepinephrine; Nucleus Accumbens; Rats; Rats, Inbred Strains | 1990 |
Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.
Topics: Animals; Behavior, Animal; Brain Chemistry; Cholecystokinin; Diazepam; Exploratory Behavior; Flunitrazepam; In Vitro Techniques; Male; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Synaptosomes | 1990 |
Cholecystokinin antagonism by benzodiazepines in the contractile response of the isolated guinea-pig gallbladder.
Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Atropine; Bradykinin; Chlordiazepoxide; Cholecystokinin; Diazepam; Gallbladder; Gallopamil; Guinea Pigs; Histamine; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Medazepam; Muscle Contraction; Muscle, Smooth; Naloxone; Sincalide | 1985 |
Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788.
Topics: Analgesics; Animals; Anti-Anxiety Agents; Benzodiazepinones; Chlordiazepoxide; Cholecystokinin; Diazepam; Flumazenil; Flurazepam; Male; Mice; Morphine; Naloxone; Pain; Sensory Thresholds; Time Factors | 1985 |
Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brain.
Topics: Animals; Benzodiazepinones; Brain; Cholecystokinin; Devazepide; Diazepam; Male; Rats; Rats, Inbred Strains | 1987 |
Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat.
Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Cholecystokinin; Diazepam; Electrophysiology; Flurazepam; Hippocampus; Iontophoresis; Male; Neurons; Pyramidal Tracts; Rats; Rats, Inbred Strains | 1988 |
Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems.
Topics: Amino Acids; Animals; Calcium; Cerebral Cortex; Cholecystokinin; Diazepam; Male; Picrotoxin; Potassium; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Glutamate; Receptors, Neurotransmitter; Tetrodotoxin | 1987 |
Autoradiographic demonstration of the antagonism of anthramycin and diazepam against cholecystokinin in the mouse brain using the [14C]-2-deoxyglucose method.
Topics: Animals; Anthramycin; Autoradiography; Benzodiazepinones; Biological Transport, Active; Brain; Cholecystokinin; Deoxyglucose; Diazepam; Male; Mice | 1988 |
Effect of a cholecystokinin antagonist on some effects of diazepam.
Topics: Animals; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Glutamine; Male; Mice; Mice, Inbred Strains; Motor Activity; Pentylenetetrazole; Proglumide; Seizures | 1987 |
Anticonvulsant effects of careulein and cholecystokinin octapeptide, compared with those of diazepam.
Topics: Animals; Anticonvulsants; Bicuculline; Ceruletide; Cholecystokinin; Diazepam; Kinetics; Male; Mice; Pentylenetetrazole; Seizures; Sincalide; Strychnine; Time Factors | 1980 |
Stress-induced eating is mediated through endogenous opiates.
Topics: Animals; Behavior, Animal; Cholecystokinin; Diazepam; Eating; Endorphins; Male; Naloxone; Rats; Receptors, Opioid; Stress, Physiological | 1980 |
Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.
Topics: Animals; Behavior, Animal; Ceruletide; Cholecystokinin; Diazepam; Drug Interactions; Hexobarbital; Male; Mice; Naloxone; Sincalide; Sleep | 1980 |
Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
Topics: Animals; Anticonvulsants; Ceruletide; Cholecystokinin; Diazepam; Haloperidol; Harmine; Isoniazid; Male; Mice; Mice, Inbred Strains; Seizures; Semicarbazides; Sincalide | 1981 |
Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
Topics: Animals; Anticonvulsants; Catalepsy; Central Nervous System Depressants; Ceruletide; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Mice; Receptors, Dopamine; Sincalide; Sleep; Stereotyped Behavior | 1981 |
Cholecystokinin reduces exploratory behavior in mice.
Topics: Animals; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Exploratory Behavior; Feeding Behavior; Female; Gastrins; Male; Mice; Mice, Inbred Strains; Peptide Fragments; Sincalide | 1981 |
Caerulein and cholecystokinin octapeptide (CCK-8): sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788.
Topics: Animals; Anticonvulsants; Benzodiazepinones; Blepharoptosis; Body Temperature; Ceruletide; Cholecystokinin; Diazepam; Flumazenil; Harmine; Hypnotics and Sedatives; Male; Mice; Peptide Fragments; Seizures; Sincalide | 1982 |
Effects of sequential removal of rats from a group cage, and of individual housing of rats, on substance P, cholecystokinin and somatostatin levels in the periaqueductal grey and limbic regions.
Topics: Amygdala; Animals; Brain; Cholecystokinin; Dexamethasone; Diazepam; Hippocampus; Limbic System; Male; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Social Isolation; Somatostatin; Stress, Psychological; Substance P | 1994 |
Gastrointestinal effects of diazepam-withdrawal are linked to activation of central cholecystokinin-ergic pathways in rats.
Topics: Animals; Benzodiazepinones; Brain; Cholecystokinin; Devazepide; Diazepam; Flumazenil; Gastrointestinal Motility; Gastrointestinal Transit; Male; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Substance Withdrawal Syndrome | 1994 |
Application of 'nose-poke habituation' validation with post-trial diazepam- and cholecystokinin-induced hypo- and hypermnesia.
Topics: Animals; Cholecystokinin; Diazepam; Dose-Response Relationship, Drug; Habituation, Psychophysiologic; Injections, Intraperitoneal; Male; Memory; Rats; Rats, Wistar | 1995 |
Chronic pain-related behaviors in spinally injured rats: evidence for functional alterations of the endogenous cholecystokinin and opioid systems.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Cholecystokinin; Chronic Disease; Diazepam; Endorphins; Female; Indoles; Meglumine; Naloxone; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Spinal Cord Injuries; Vocalization, Animal | 1994 |
The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.
Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Reflex, Startle; Substance Withdrawal Syndrome | 1993 |
The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response.
Topics: Acoustic Stimulation; Animals; Cholecystokinin; Diazepam; Male; Pyrazoles; Rats; Receptors, Cholecystokinin; Reflex, Startle; Substance Withdrawal Syndrome; Time Factors | 1994 |
Benzodiazepines increase preprocholecystokinin messenger RNA levels in rat brain.
Topics: Animals; Anxiety; Base Sequence; Benzodiazepines; Biomarkers; Brain Chemistry; Cholecystokinin; Diazepam; In Situ Hybridization; Male; Molecular Sequence Data; Protein Precursors; Rats; RNA, Messenger; Substance Withdrawal Syndrome | 1993 |
Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat: prevention by diazepam but not ondansetron.
Topics: Administration, Inhalation; Animals; Cholecystokinin; Chromatography, High Pressure Liquid; Diazepam; Ether; Frontal Lobe; Male; Ondansetron; Potassium; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological; Yohimbine | 1996 |
Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
Topics: Amylases; Animals; Anorexia; Anti-Anxiety Agents; Benzodiazepinones; Carbamates; Cholecystokinin; Devazepide; Diazepam; Disease Models, Animal; Fenfluramine; Guinea Pigs; Hormone Antagonists; Locomotion; Male; Mice; Phenylurea Compounds; Pyrimidinones; Rats; Rats, Wistar; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors | 1997 |
Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.
Topics: Animals; Anxiety; Behavior, Animal; Cholecystokinin; Diazepam; Gene Expression; Mice; Mice, Transgenic; Prosencephalon; Receptor, Cholecystokinin B | 2006 |
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.
Topics: Adrenocorticotropic Hormone; Adult; Anti-Anxiety Agents; Anti-Ulcer Agents; Anxiety; Cholecystokinin; Diazepam; Female; Humans; Hydrocortisone; Hyperalgesia; Hypothalamo-Hypophyseal System; Male; Middle Aged; Opioid Peptides; Pituitary-Adrenal System; Placebo Effect; Proglumide; Psychophysiologic Disorders; Receptors, Cholecystokinin | 2006 |
Neuropeptides modulate compound postsynaptic potentials in basolateral amygdala.
Topics: Action Potentials; Amygdala; Animals; Anti-Anxiety Agents; Cations, Monovalent; Chlorides; Cholecystokinin; Corticotropin-Releasing Hormone; Diazepam; Gap Junctions; Homeostasis; Male; Mefloquine; Neuropeptide Y; Neuropeptides; Patch-Clamp Techniques; Periodicity; Potassium; Rats; Receptors, GABA; Receptors, Glutamate; Somatostatin; Synaptic Potentials | 2009 |